Affiliation:
1. Division of Gastroenterology, Biomedical Research Institute, Pusan National University Hospital, Busan 49241, Republic of Korea
2. Department of Internal Medicine, College of Medicine, Pusan National University, Yangsan 50612, Republic of Korea
3. Department of Internal Medicine, CHA Gumi Medical Center, CHA University, Gumi-si 39295, Republic of Korea
Abstract
Background/Objectives: Endoscopic papillectomy (EP) is the preferred treatment for ampullary tumors because it has fewer side effects than surgical removal. This study retrospectively compared a new anchoring EP method (A-EP) with the conventional (C-EP) approach. Methods: Ninety-nine patients who underwent EP at a single medical institution between 2009 and 2021 were retrospectively reviewed. In all patients, the indications for EP were pathological adenoma with <10 mm of biliary invasion and a tumor diameter <30 mm on endoscopic ultrasonography. The exclusion criteria were antiplatelet/anticoagulant use, previous upper GI surgery, or prior biliary/pancreatic endoscopic therapy. One expert endoscopist performed the two types of EPs, A-EP and C-EP. Results: Sixty-two patients underwent A-EP, and 37 underwent C-EP. There were no significant differences in baseline characteristics, such as sex, age, tumor size, and ductal invasion on endoscopic ultrasound. The A-EP group had higher en bloc resection rates (95.2% vs. 78.4%, p = 0.010). Although the difference was not statistically significant, it tended towards fewer incidences of pancreatitis (p = 0.081) and duct stricture (p = 0.081). The recurrence rate was lower in the A-EP group (8.1% vs. 37.8%, p = 0.000). There were no significant differences between the two groups regarding the follow-up period (A-EP vs. C-EP, 725 vs. 1045 days, p = 0.109) or the days of recurrence (A-EP vs. C-EP, 341 vs. 562 days, p = 0.551). Conclusions: A-EP showed better outcomes than C-EP in terms of en bloc resection and recurrence rates, providing evidence for the efficacy of this novel EP method.
Funder
National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea
Reference41 articles.
1. Demographics, tumor characteristics, treatment, and clinical outcomes of patients with ampullary cancer: A Surveillance, Epidemiology, and End Results (SEER) cohort study;Ramai;Minerva Gastroenterol. Dietol.,2019
2. Trends in incidence and management of cancer of the ampulla of Vater;Rostain;World J. Gastroenterol.,2014
3. Endoscopic snare papillectomy for tumors of the duodenal papillae;Cheng;Gastrointest. Endosc.,2004
4. Clinicopathologic correlation of p53 protein overexpression in adenoma and carcinoma of the ampulla of Vater;Park;World J. Surg.,2000
5. Incidence and comparative outcomes of periampullary cancer: A population-based analysis demonstrating improved outcomes and increased use of adjuvant therapy from 2004 to 2012;Hester;J. Surg. Oncol.,2019